iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development

03.02.2022 iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development | Chief Medical Officer | Dr. Murray Yule

Related Keywords

Germany ,Martinsried ,Bayern ,Wellington ,New Zealand General ,New Zealand ,Houston ,Texas ,United States ,United Kingdom ,German ,Athos Biopharma ,Apollon Papadimitriou ,Katja Arnold ,Philipp Beckhove ,Murray Yule ,Nisit Khandelwal ,Shaun Brown ,Mc Services ,Md Anderson Cancer Centre ,Nasdaq ,German Cancer Research Center ,Clinical Development ,Omx Therapeutics Appoints ,Lead Clinical ,Omx Therapeutics ,Chief Medical Officer ,Clinical Trial Application ,Cancer Centre ,Hodgkin Lymphoma ,Scientific Boards ,Almac Discovery ,Wellington Partners ,Sofinnova Partners ,R Murray Yule ,Mmune Checkpoint Target ,Mt 07 ,Biomx ,Ncology ,Solid Tumors , ,